top of page
Home: Welcome

Spring 2025
Search


The Double-Edged Sword of Genetic Editing
Authored by: Suri Wang Art by: Claire Ma The genetic code acts as the instruction manual for every living organism, determining traits such as eye color, skin tone, and sex. Over the past 50 years, scientists or researchers discovered a way to manipulate the code: genetic engineering, the deliberate alteration of DNA. In 2013, scientists approved CRISPR-Cas9, a precise gene-editing tool that modifies DNA at targeted sites. While genetic editing offers advances in treating neu
Suri Wang
Jan 64 min read


Racial Inequities in Severe Maternal Health Outcomes
Authored by: Surabhi Shastry Art by: Stefanie Chen Racial inequities in severe maternal morbidity (SMM) and pregnancy-related mortality in the United States are a critical, persistent public health crisis. National data consistently show that Black birthing people face pregnancy-related deaths and SMM at rates three times higher than White birthing people, and these disparities have not shown substantial improvement over time [1]. State-level analyses reveal that the magnitud
Surabhi Shastry
Jan 64 min read


Weaponizing Section 1498 Against GLP-1 Manufacturers
Authored by: Sriram Chakravadhanula Art by: Carol Zhang In March 2024, the U.S. Food and Drug Administration (FDA) approved GLP-1 medication for heart disease, in addition to its application for diabetes, leading to a massive increase in GLP-1 users. The United States became the largest market for Ozempic and Wegovy supplier, Novo Nordisk, with over 71% of the Company’s drug sales come from the United States[1]. As Senator Warren revealed, Ozempic is priced at $936 in the US
Sriram Chakravadhanula
Jan 64 min read
CONTACT
bottom of page


